Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. NLM AIDSLINE Important note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules.

Infect Immun. 1982 Aug;37(2):432-8. Unique Identifier : AIDSLINE MED/83005786
Morse SA; Lysko PG; McFarland L; Knapp JS; Sandstrom E; Critchlow C; Holmes KK


Abstract: Loci designated penA, penB, and mtr contribute additively to penicillin G resistance in Neisseria gonorrhoeae; the mtr locus also confers resistance to hydrophobic dyes, detergents, and antibiotics, env mutations suppress the phenotypic expression of mtr and penB and are responsible for increased sensitivity to various hydrophobic molecules. We postulated that the host environment is important in the selection of gonococcal strains with these particular outer membrane phenotypes. Thus, mtr strains should predominate in environments that are high in hydrophobic molecules. To test this hypothesis we determined the outer membrane phenotype of 152 strains of N. gonorrhoeae. Rectal and urethral isolates from 58 homosexual men, urethral isolates from 55 heterosexual men, and cervical and rectal isolates from 39 heterosexual women were used in this study. Strains from 43 of the homosexual men were matched with those from heterosexual men with respect to auxotype and year and season of isolation. Cell envelope phenotype was determined for each strain on the basis of its resistance to various hydrophobic compounds. The identity of mtr strains was confirmed by genetic transformation. Among the matched pairs, mtr strains were significantly more prevalent among isolates from homosexual men than among those from heterosexual men (P = 0.03). Serogrouping by coagglutination demonstrated that 17 of 19 mtr strains versus 76 of 131 non-mtr strains belonged to coagglutination group WII (P = 0.01). Coagglutination group WII strains were also associated with homosexuality (P = 0.02). Gonococci were also tested for resistance to fecal lipids, mtr strains were more resistant to growth inhibition by fecal lipids than were non-mtr strains.
Keywords: Bacterial Proteins/ANALYSIS Cell Membrane Permeability/*DRUG EFFECTS Cell Wall/ANALYSIS/IMMUNOLOGY Erythromycin/PHARMACOLOGY Feces/ANALYSIS Female Gonorrhea/*IMMUNOLOGY/PSYCHOLOGY *Homosexuality Human Lipids/PHARMACOLOGY Male Membrane Proteins/ANALYSIS Microbial Sensitivity Tests Molecular Weight Neisseria gonorrhoeae/*ANALYSIS/GROWTH & DEVELOPMENT/GENETICS Penicillin G/PHARMACOLOGY Phenotype Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Transformation, Bacterial JOURNAL ARTICLE

KWDbacterialproteins/analysiscellmembranepermeability/KWDdrugeffectscellwall/analysis/immunologyerythromycin/pharmacologyfeces/analysisfemalegonorrhea/KWDimmunology/psychologyKWDhomosexualityhumanlipids/pharmacologymalemembraneproteins/analysismicrobialsensitivitytestsmolecularweightneisseriagonorrhoeae/KWDanalysis/growth&development/geneticspenicilling/pharmacologyphenotypesupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDtransformation,bacterialjournalarticle
830130
M8310008


Copyright © 1983 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1983. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1983. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .